Oct 1 (Reuters) – Wave Life Sciences Ltd.: * WAVE LIFE SCIENCES ANNOUNCES FDA FEEDBACK SUPPORTS REGISTRATIONAL PATHWAY FOR WVE-006 (RNA EDITING) IN AATD * WAVE LIFE SCIENCES – PLANS TWO-YEAR
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Saeed Azhar, Max A. Cherney, Isla Binnie and Stephen Nellis NEW YORK, Oct 1…
WASHINGTON, Oct 1 (Reuters) - New applications for US unemployment benefits fell last week and…
Oct 1 (Reuters) - Unimot SA: * SIGNS DEAL TO ACQUIRE 34.2% STAKE IN PZL…
VIDEO SHOWS: JAPANESE TENNIS PLAYER, KEI NISHIKORI, SPEAKING DURING ON COURT INTERVIEW AFTER LOSING FIRST…
Celebrating India’s Forest Officers & Conservationists: Veerappan’s Nemesis BK Singh Wins Lifetime Achievement Award; 15…
By Johann M Cherian and Tharuniyaa Lakshmi Oct 1 (Reuters) - U.S. stock index futures…